Ethical Issues in Phase I Cancer Clinical Trials
- 1 January 2006
- journal article
- Published by Springer Nature in International Journal of Pharmaceutical Medicine
- Vol. 20 (4) , 233-242
- https://doi.org/10.2165/00124363-200620040-00003
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Revisions of and Clarifications to the ASCO Conflict of Interest PolicyJournal of Clinical Oncology, 2006
- Therapeutic misconception in early phase gene transfer trialsSocial Science & Medicine, 2006
- Pediatric Phase I Trials in Oncology: An Analysis of Study Conduct EfficiencyJournal of Clinical Oncology, 2005
- Presentation and subsequent publication rates of phase I oncology clinical trialsCancer, 2005
- Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002New England Journal of Medicine, 2005
- Offering participants results of a clinical trial: sharing results of a negative studyThe Lancet, 2005
- Perceptions of Patients and Physicians Regarding Phase I Cancer Clinical Trials: Implications for Physician-Patient CommunicationJournal of Clinical Oncology, 2003
- The correlation between patient characteristics and expectations of benefit from Phase I clinical trialsCancer, 2003
- Quality of informed consent in cancer clinical trials: a cross-sectional surveyThe Lancet, 2001
- Informed consent for clinical trials: in search of the “best” methodSocial Science & Medicine, 1998